Ina Møller
Bakgrunn og aktiviteter
Vitenskapelig, faglig og kunstnerisk arbeid
Et utvalg av nyere tidsskriftspublikasjoner, kunstneriske produksjoner, bok, inklusiv bokdeler og rapport-del. Se alle publikasjoner i databasen
Tidsskriftspublikasjoner
- (2018) Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease. Alzheimer's Research & Therapy. vol. 10:9.
- (2018) The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease. Acta neuropathologica communications. vol. 6.
- (2017) Cerebrospinal fluid levels of amyloid beta 1-43 mirror 1-42 in relation to imaging biomarkers of Alzheimer's disease. Frontiers in Aging Neuroscience. vol. 9.
- (2017) Cerebrospinal fluid Aβ43 is reduced in early-onset compared to late-onset Alzheimer's disease, but has similar diagnostic accuracy to Aβ42. Frontiers in Aging Neuroscience. vol. 9 (210).
- (2016) Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy controls: a two year follow-up study. BMC Neurology. vol. 16 (180).
- (2016) Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study. Frontiers in Aging Neuroscience. vol. 8.
- (2015) Effect of tween-20 on core biomarkers measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy control individuals. Journal of Alzheimer's Disease. vol. 49 (2).